Page last updated: 2024-10-27

gaboxadol and Disease Models, Animal

gaboxadol has been researched along with Disease Models, Animal in 26 studies

gaboxadol: GABA agonist; inhibitor of GABA uptake systems; structure

Disease Models, Animal: Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases.

Research Excerpts

ExcerptRelevanceReference
"Epileptiform discharges recorded in the 4-aminopyridine (4-AP) in vitro epilepsy model are mediated by glutamatergic and GABAergic signaling."7.77The 4-aminopyridine in vitro epilepsy model analyzed with a perforated multi-electrode array. ( Avoli, M; Dzakpasu, R; Gonzalez-Sulser, A; Motamedi, GK; Vicini, S; Wang, J, 2011)
"Epileptiform discharges recorded in the 4-aminopyridine (4-AP) in vitro epilepsy model are mediated by glutamatergic and GABAergic signaling."3.77The 4-aminopyridine in vitro epilepsy model analyzed with a perforated multi-electrode array. ( Avoli, M; Dzakpasu, R; Gonzalez-Sulser, A; Motamedi, GK; Vicini, S; Wang, J, 2011)
"The psychotomimetic NMDA receptor antagonist phencyclidine (PCP) is frequently employed to model schizophrenia in animal disease models."3.77Extrasynaptic GABAA receptor activation reverses recognition memory deficits in an animal model of schizophrenia. ( Damgaard, T; Hansen, SL; Neill, JC; Plath, N, 2011)
"The anticonvulsant efficacy of the GABAmimetic drugs cetyl GABA, progabide and THIP (4,5,6,7-tetrahydroisoxazolo [5,4-c] pyridine-3-ol) was studied against minor (myoclonic) and major (generalized tonic-clonic) seizures in gerbils as well as against maximal electroshock and s."3.67Anticonvulsant action of GABA agonists and prodrugs on minor and major seizures in epileptic gerbils. Comparison with mouse models of seizure states. ( Löscher, W, 1985)
"Seven GABAmimetic drugs, namely cetyl gamma-aminobutyric acid (cetyl GABA), 4,5,6,7-tetrahydroisoxazolo [5,4-c]pyridine-3-ol, progabide, aminooxyacetic acid, alpha-acetylenic GABA, (-)-nipecotic acid ethyl ester and (+/-)-cis-4-hydroxynipecotic acid methyl ester, were tested for their potency to block "major" (generalized clonic-tonic) seizures in gerbils, induced by blowing at the animals with compressed air."3.66High anticonvulsant potency of gamma-aminobutyric acid (GABA)mimetic drugs in gerbils with genetically determined epilepsy. ( Frey, HH; Löscher, W; Reiche, R; Schultz, D, 1983)
"Autism spectrum disorder is a neurodevelopmental syndrome diagnosed primarily by persistent deficits in social interactions and communication, unusual sensory reactivity, motor stereotypies, repetitive behaviors, and restricted interests."1.51Hypothesis-driven investigations of diverse pharmacological targets in two mouse models of autism. ( Crawley, JN; Kazdoba, TM; Parrott, JM; Rhine, MA; Schultz, MN, 2019)
"Alterations in the Duchenne muscular dystrophy (DMD) gene have been associated with enhanced stress reactivity in vertebrate species, suggesting a role for brain dystrophin in fear-related behavioral and cognitive processes."1.46Relationships linking emotional, motor, cognitive and GABAergic dysfunctions in dystrophin-deficient mdx mice. ( Chaussenot, R; Vaillend, C, 2017)
"Angelman syndrome is a neurodevelopmental disorder caused by loss of function of the UBE3A gene encoding a ubiquitin E3 ligase."1.38Decreased tonic inhibition in cerebellar granule cells causes motor dysfunction in a mouse model of Angelman syndrome. ( Egawa, K; Fukuda, A; Inoue, K; Kishino, T; Kitagawa, K; Kitagawa, M; Saitoh, S; Takayama, C; Takayama, M, 2012)
"Animal models of neuropathic pain have enabled the identification of key pathophysiological changes occurring within nociceptive pathways as a result of injury, and serve an invaluable role for preclinical screening of novel analgesic candidates."1.34The importance of genetic background on pain behaviours and pharmacological sensitivity in the rat spared serve injury model of peripheral neuropathic pain. ( Bjerrum, OJ; Blackburn-Munro, G; Broløs, T; Jensen, DG; Rode, F; Thomsen, M, 2007)

Research

Studies (26)

TimeframeStudies, this research(%)All Research%
pre-19904 (15.38)18.7374
1990's1 (3.85)18.2507
2000's3 (11.54)29.6817
2010's17 (65.38)24.3611
2020's1 (3.85)2.80

Authors

AuthorsStudies
Solinski, HJ1
Dranchak, P1
Oliphant, E1
Gu, X1
Earnest, TW1
Braisted, J1
Inglese, J1
Hoon, MA1
Abrams, RPM1
Yasgar, A1
Teramoto, T1
Lee, MH1
Dorjsuren, D1
Eastman, RT1
Malik, N1
Zakharov, AV1
Li, W1
Bachani, M1
Brimacombe, K1
Steiner, JP1
Hall, MD1
Balasubramanian, A1
Jadhav, A1
Padmanabhan, R1
Simeonov, A1
Nath, A1
Rhine, MA1
Parrott, JM1
Schultz, MN1
Kazdoba, TM1
Crawley, JN1
Wan, L1
Liu, X1
Wu, Z1
Ren, W1
Kong, S1
Dargham, RA1
Cheng, L1
Wang, Y1
González, MI1
Grabenstatter, HL1
Cea-Del Rio, CA1
Cruz Del Angel, Y1
Carlsen, J1
Laoprasert, RP1
White, AM1
Huntsman, MM2
Brooks-Kayal, A1
Dissel, S1
Angadi, V1
Kirszenblat, L1
Suzuki, Y1
Donlea, J1
Klose, M1
Koch, Z1
English, D1
Winsky-Sommerer, R1
van Swinderen, B1
Shaw, PJ1
Boychuk, JA2
Butler, CR2
Halmos, KC1
Smith, BN2
Zhong, W1
Johnson, CM1
Cui, N1
Xing, H1
Wu, Y1
Jiang, C1
Vaillend, C1
Chaussenot, R1
Holm, MM1
Nieto-Gonzalez, JL1
Vardya, I1
Henningsen, K1
Jayatissa, MN1
Wiborg, O2
Jensen, K1
Olmos-Serrano, JL2
Paluszkiewicz, SM1
Martin, BS1
Kaufmann, WE1
Corbin, JG2
Gonzalez-Sulser, A1
Wang, J1
Motamedi, GK1
Avoli, M1
Vicini, S1
Dzakpasu, R1
Damgaard, T1
Plath, N1
Neill, JC1
Hansen, SL1
Kueh, SL1
Dempster, J1
Head, SI1
Morley, JW1
Burns, MP1
Christensen, T1
Bétry, C1
Mnie-Filali, O1
Etievant, A1
Ebert, B1
Haddjeri, N1
Egawa, K1
Kitagawa, K1
Inoue, K1
Takayama, M1
Takayama, C1
Saitoh, S1
Kishino, T1
Kitagawa, M1
Fukuda, A1
Rode, F2
Jensen, DG2
Blackburn-Munro, G2
Bjerrum, OJ2
Thomsen, M1
Broløs, T1
Löscher, W2
Frey, HH1
Reiche, R1
Schultz, D1
Golden, GT1
Fariello, RG1
Rudissaar, R1
Pruus, K1
Skrebuhhova-Malmros, T1
Allikmets, L1
Matto, V1
Snead, OC1
Chapman, AG1

Reviews

2 reviews available for gaboxadol and Disease Models, Animal

ArticleYear
Pharmacological models of generalized absence seizures in rodents.
    Journal of neural transmission. Supplementum, 1992, Volume: 35

    Topics: Animals; Disease Models, Animal; Epilepsy, Absence; Isoxazoles; Penicillins; Pentylenetetrazole; Rod

1992
Valproate and myoclonus.
    Advances in neurology, 1986, Volume: 43

    Topics: 5-Hydroxytryptophan; Amino Acids; Animals; Aspartic Acid; Clonazepam; DDT; Disease Models, Animal; F

1986

Other Studies

24 other studies available for gaboxadol and Disease Models, Animal

ArticleYear
Inhibition of natriuretic peptide receptor 1 reduces itch in mice.
    Science translational medicine, 2019, 07-10, Volume: 11, Issue:500

    Topics: Animals; Behavior, Animal; Cell-Free System; Dermatitis, Contact; Disease Models, Animal; Ganglia, S

2019
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
    Proceedings of the National Academy of Sciences of the United States of America, 2020, 12-08, Volume: 117, Issue:49

    Topics: Animals; Antiviral Agents; Artificial Intelligence; Chlorocebus aethiops; Disease Models, Animal; Dr

2020
Hypothesis-driven investigations of diverse pharmacological targets in two mouse models of autism.
    Autism research : official journal of the International Society for Autism Research, 2019, Volume: 12, Issue:3

    Topics: Animals; Autism Spectrum Disorder; Behavior, Animal; Brain; Cognition; Disease Models, Animal; Groom

2019
Activation of extrasynaptic GABA(A) receptors inhibits cyclothiazide-induced epileptiform activity in hippocampal CA1 neurons.
    Neuroscience bulletin, 2014, Volume: 30, Issue:5

    Topics: Animals; Benzothiadiazines; CA1 Region, Hippocampal; Convulsants; Disease Models, Animal; GABA Agoni

2014
Seizure-related regulation of GABAA receptors in spontaneously epileptic rats.
    Neurobiology of disease, 2015, Volume: 77

    Topics: Animals; Biotinylation; Disease Models, Animal; Excitatory Amino Acid Antagonists; GABA Agonists; Ge

2015
Sleep restores behavioral plasticity to Drosophila mutants.
    Current biology : CB, 2015, May-18, Volume: 25, Issue:10

    Topics: Adenylyl Cyclases; Alzheimer Disease; Animals; Animals, Genetically Modified; Behavior, Animal; Dise

2015
Enduring changes in tonic GABAA receptor signaling in dentate granule cells after controlled cortical impact brain injury in mice.
    Experimental neurology, 2016, Volume: 277

    Topics: Anesthetics; Animals; Brain Injuries; Cerebral Cortex; Dentate Gyrus; Desoxycorticosterone; Disease

2016
Differential effects of rapamycin treatment on tonic and phasic GABAergic inhibition in dentate granule cells after focal brain injury in mice.
    Experimental neurology, 2016, Volume: 280

    Topics: Anesthetics; Animals; Brain Injuries; Dentate Gyrus; Disease Models, Animal; Functional Laterality;

2016
Effects of chronic exposure to low dose THIP on brainstem neuronal excitability in mouse models of Rett syndrome: Evidence from symptomatic females.
    Neuropharmacology, 2017, Volume: 116

    Topics: Animals; Brain Stem; Disease Models, Animal; Dose-Response Relationship, Drug; Double-Blind Method;

2017
Relationships linking emotional, motor, cognitive and GABAergic dysfunctions in dystrophin-deficient mdx mice.
    Human molecular genetics, 2017, 03-15, Volume: 26, Issue:6

    Topics: Animals; Brain; Cognition; Disease Models, Animal; Dystrophin; Fear; GABAergic Neurons; Humans; Isox

2017
Hippocampal GABAergic dysfunction in a rat chronic mild stress model of depression.
    Hippocampus, 2011, Volume: 21, Issue:4

    Topics: Action Potentials; Animals; Antidepressive Agents, Second-Generation; Citalopram; Dentate Gyrus; Dep

2011
Defective GABAergic neurotransmission and pharmacological rescue of neuronal hyperexcitability in the amygdala in a mouse model of fragile X syndrome.
    The Journal of neuroscience : the official journal of the Society for Neuroscience, 2010, Jul-21, Volume: 30, Issue:29

    Topics: Amygdala; Animals; Disease Models, Animal; Evoked Potentials; Fragile X Mental Retardation Protein;

2010
The 4-aminopyridine in vitro epilepsy model analyzed with a perforated multi-electrode array.
    Neuropharmacology, 2011, Volume: 60, Issue:7-8

    Topics: 4-Aminopyridine; Animals; Anticonvulsants; Bicuculline; CA3 Region, Hippocampal; Disease Models, Ani

2011
Extrasynaptic GABAA receptor activation reverses recognition memory deficits in an animal model of schizophrenia.
    Psychopharmacology, 2011, Volume: 214, Issue:2

    Topics: Analysis of Variance; Animals; Behavior, Animal; Disease Models, Animal; Dose-Response Relationship,

2011
Reduced postsynaptic GABAA receptor number and enhanced gaboxadol induced change in holding currents in Purkinje cells of the dystrophin-deficient mdx mouse.
    Neurobiology of disease, 2011, Volume: 43, Issue:3

    Topics: Animals; Disease Models, Animal; Female; GABA Agonists; GABA Antagonists; Isoxazoles; Male; Mice; Mi

2011
The GABA(A) receptor agonist THIP ameliorates specific behavioral deficits in the mouse model of fragile X syndrome.
    Developmental neuroscience, 2011, Volume: 33, Issue:5

    Topics: Animals; Behavior, Animal; Conditioning, Psychological; Disease Models, Animal; Fear; Fragile X Ment

2011
Synergistic antidepressant-like action of gaboxadol and escitalopram.
    European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 2012, Volume: 22, Issue:10

    Topics: Animals; Antidepressive Agents; Behavior, Animal; Citalopram; Dentate Gyrus; Depression; Disease Mod

2012
Decreased tonic inhibition in cerebellar granule cells causes motor dysfunction in a mouse model of Angelman syndrome.
    Science translational medicine, 2012, Dec-05, Volume: 4, Issue:163

    Topics: Angelman Syndrome; Animals; Cerebellum; Disease Models, Animal; GABA Agonists; GABA Plasma Membrane

2012
Centrally-mediated antinociceptive actions of GABA(A) receptor agonists in the rat spared nerve injury model of neuropathic pain.
    European journal of pharmacology, 2005, Jun-01, Volume: 516, Issue:2

    Topics: Analgesics; Animals; Disease Models, Animal; Dose-Response Relationship, Drug; GABA Agonists; GABA-A

2005
The importance of genetic background on pain behaviours and pharmacological sensitivity in the rat spared serve injury model of peripheral neuropathic pain.
    European journal of pharmacology, 2007, Jun-14, Volume: 564, Issue:1-3

    Topics: Amines; Analgesics; Analgesics, Opioid; Animals; Cyclohexanecarboxylic Acids; Disease Models, Animal

2007
High anticonvulsant potency of gamma-aminobutyric acid (GABA)mimetic drugs in gerbils with genetically determined epilepsy.
    The Journal of pharmacology and experimental therapeutics, 1983, Volume: 226, Issue:3

    Topics: Alkynes; Aminocaproates; Aminooxyacetic Acid; Animals; Anticonvulsants; Diazepam; Disease Models, An

1983
Penicillin spikes in rats. Limitations of a simple model for the study of anticonvulsants.
    Neuropharmacology, 1984, Volume: 23, Issue:9

    Topics: Action Potentials; Animals; Anticonvulsants; Dimethyl Sulfoxide; Disease Models, Animal; Drug Evalua

1984
Involvement of GABAergic neurotransmission in the neurobiology of the apomorphine-induced aggressive behavior paradigm, a model of psychotic behavior in rats.
    Methods and findings in experimental and clinical pharmacology, 2000, Volume: 22, Issue:8

    Topics: Aggression; Animals; Apomorphine; Baclofen; Behavior, Animal; Disease Models, Animal; GABA Agonists;

2000
Anticonvulsant action of GABA agonists and prodrugs on minor and major seizures in epileptic gerbils. Comparison with mouse models of seizure states.
    Archives internationales de pharmacodynamie et de therapie, 1985, Volume: 276, Issue:2

    Topics: Animals; Anticonvulsants; Disease Models, Animal; Electroshock; Female; gamma-Aminobutyric Acid; Ger

1985